About: Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.45 (-8.41%)
VYGR NASDAQ Voyager Therapeutics Inc
Voyager Therapeutics Inc share price
VYGR price activity
Last Price
$2.450
Change (24hr)
-0.23 USD (-8.41%)
Volume
1.15M
Volume (4w avg)
-
Open
$2.72
Day Range
$2.42 - $2.73
Previous Close
$2.68
Last Trade
02 Oct, 8:22 pm GMT+0
Delayed
02 Oct, 8:22 pm GMT+0
VYGR price performance
Delayed
02 Oct, 8:22 pm GMT+0
VYGR Market Signals